UCLA Hematology/Oncology - Santa Barbara

Clinical research site in Santa Barbara, California · 540 W PUEBLO ST, SANTA BARBARA, CA 93105-4230 · (805) 563-5800

Part of UCLA

As of July 2026, 1 paid clinical trial is recruiting at UCLA Hematology/Oncology - Santa Barbara in Santa Barbara, California. Active studies at this site cover conditions such as Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer and Prostate Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at UCLA Hematology/Oncology - Santa Barbara (1)

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

for Metastatic Castration Sensitive Prostate Cancer (mCSPC)

122 locations incl. Huntsville

Sponsor: Pfizer

Sex: Male·Age: 18+

Code: NCT07028853·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

Explore more

Paid clinical trials in Santa Barbara, CA · California clinical trials

UCLA Hematology/Oncology - Santa Barbara

Recruiting clinical trials at UCLA Hematology/Oncology - Santa Barbara (1)

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

More research sites in Santa Barbara

Explore more